Alligator Bioscience AB (publ) (ATORX.ST)
ATORX.ST Stock Price Chart
Explore Alligator Bioscience AB (publ) interactive price chart. Choose custom timeframes to analyze ATORX.ST price movements and trends.
ATORX.ST Company Profile
Discover essential business fundamentals and corporate details for Alligator Bioscience AB (publ) (ATORX.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
23 Nov 2016
Employees
33.00
CEO
Søren Bregenholt
Description
Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based drugs for cancer treatment in Sweden. It develops products using its technology platforms, including ALLIGATOR-GOLD and ALLIGATOR-FAB, a proprietary human antibody library that contains approximately 60 billion unique antibody fragments; FIND, a molecular evolution technology for optimization of antibodies and other proteins; and RUBY, a bispecific antibody format. The company develops Mitazalimab, an immunostimulatory CD40 antibody, which has completed Phase I clinical trial for the treatment of metastatic cancer; and ATOR-1017, an immunostimulatory antibody, which is in phase I clinical trial that binds to the receptor 4-1BB in tumor-specific T cells. Its drug candidates in the preclinical development stage include ALG.APV-527, a bispecific 4-1BB and 5T4 antibody for the treatment of cancer. The company also holds a stake in clinical project Biosynergy (AC101), which is in phase I clinical trial. It has a partnership agreement with Aptevo Therapeutics Inc. for the co-development of ALG.APV-527; and a research collaboration with MacroGenics, Inc. to develop a novel immunotherapy. The company also has a joint research agreement with BioArctic AB (publ) to employ proprietary antibody generation technologies for developing new product candidates; and a research collaboration and license agreement with the Orion Corporation to discover and develop new bispecific antibody cancer therapeutics. Alligator Bioscience AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
ATORX.ST Financial Timeline
Browse a chronological timeline of Alligator Bioscience AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 22 Apr 2026
Upcoming earnings on 12 Feb 2026
Upcoming earnings on 23 Oct 2025
Earnings released on 10 Jul 2025
EPS came in at -kr 0.08 .
Earnings released on 24 Apr 2025
EPS came in at -kr 1.11 , while revenue for the quarter reached kr 5.18M .
Stock split effective on 7 Apr 2025
Shares were split 1 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 22 Jan 2025
EPS came in at -kr 6.18 , while revenue for the quarter reached kr 41.78M .
Earnings released on 24 Oct 2024
EPS came in at -kr 7.42 , while revenue for the quarter reached kr 1.43M .
Earnings released on 11 Jul 2024
EPS came in at -kr 5.61 , while revenue for the quarter reached kr 7.58M .
Earnings released on 6 May 2024
EPS came in at -kr 8.06 , while revenue for the quarter reached kr 6.98M .
Earnings released on 9 Feb 2024
EPS came in at -kr 10.61 , while revenue for the quarter reached kr 11.74M .
Earnings released on 26 Oct 2023
EPS came in at -kr 8.30 , while revenue for the quarter reached kr 19.41M .
Earnings released on 13 Jul 2023
EPS came in at -kr 9.47 , while revenue for the quarter reached kr 17.36M .
Earnings released on 25 Apr 2023
EPS came in at -kr 9.50 , while revenue for the quarter reached kr 9.59M .
Earnings released on 10 Feb 2023
EPS came in at -kr 8.17 , while revenue for the quarter reached kr 20.06M .
Earnings released on 20 Oct 2022
EPS came in at -kr 7.75 , while revenue for the quarter reached kr 5.11M .
Earnings released on 12 Jul 2022
EPS came in at -kr 6.88 , while revenue for the quarter reached kr 5.17M .
Earnings released on 27 Apr 2022
EPS came in at -kr 6.52 , while revenue for the quarter reached kr 5.36M .
Earnings released on 11 Feb 2022
EPS came in at -kr 5.56 , while revenue for the quarter reached kr 5.25M .
Earnings released on 21 Oct 2021
EPS came in at -kr 5.60 , while revenue for the quarter reached kr 3.30M .
Earnings released on 13 Jul 2021
EPS came in at -kr 5.34 , while revenue for the quarter reached kr 3.78M .
Earnings released on 27 Apr 2021
EPS came in at -kr 5.27 , while revenue for the quarter reached kr 617.00K .
Earnings released on 26 Feb 2021
EPS came in at -kr 0.44 , while revenue for the quarter reached kr 166.00K .
Earnings released on 22 Oct 2020
EPS came in at -kr 0.38 , while revenue for the quarter reached kr 280.00K .
ATORX.ST Stock Performance
Access detailed ATORX.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.